Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Routy

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Cancers|February 24, 2024
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell CarcinomaFatemeh Vahidian, Fabien C Lamaze, Cédrik Bouffard, et al.
Oncoimmunology|March 26, 2019
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitorsArielle Elkrief, Layal El Raichani, Corentin Richard, et al.
Cancers|November 11, 2022
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota AnalysisTaiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, et al.
Cancers|August 12, 2023
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter StudySevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
The Oncologist|July 28, 2020
Tepotinib Efficacy in a Patient with Non-Small Cell Lung Cancer with Brain Metastasis Harboring an HLA-DRB1-MET Gene FusionFélix Blanc-Durand, Raafat Alameddine, Anthony J Iafrate, et al.
Gut Pathogens|April 11, 2025
Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitorsKhoudia Diop, Babacar Mbaye, Somayeh Nili, et al.
Archives of Microbiology|September 24, 2023
Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapyKhoudia Diop, Reilly Pidgeon, Awa Diop, et al.
Cancers|January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary StudyAbdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced MelanomaYu Shi Wang, Qing Yin Wang, Alexia Erika Moise, et al.
Frontiers in Microbiology|July 24, 2018
Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected PatientsWei Lu, Yuqing Feng, Fanhui Jing, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Cancers|February 24, 2024
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell CarcinomaFatemeh Vahidian, Fabien C Lamaze, Cédrik Bouffard, et al.
Oncoimmunology|March 26, 2019
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitorsArielle Elkrief, Layal El Raichani, Corentin Richard, et al.
Cancers|November 11, 2022
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota AnalysisTaiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, et al.
Cancers|August 12, 2023
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter StudySevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
The Oncologist|July 28, 2020
Tepotinib Efficacy in a Patient with Non-Small Cell Lung Cancer with Brain Metastasis Harboring an HLA-DRB1-MET Gene FusionFélix Blanc-Durand, Raafat Alameddine, Anthony J Iafrate, et al.
Gut Pathogens|April 11, 2025
Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitorsKhoudia Diop, Babacar Mbaye, Somayeh Nili, et al.
Archives of Microbiology|September 24, 2023
Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapyKhoudia Diop, Reilly Pidgeon, Awa Diop, et al.
Cancers|January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary StudyAbdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced MelanomaYu Shi Wang, Qing Yin Wang, Alexia Erika Moise, et al.
Frontiers in Microbiology|July 24, 2018
Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected PatientsWei Lu, Yuqing Feng, Fanhui Jing, et al.
Pageof 13